Cargando cotizaciones...
Previsión
No hay datos de analistas disponibles para esta empresa.
Noticias Ir al feed de noticias
Nature’s Miracle enters partnership with FF AI-Robotics for robotics deployment in North America
Nature’s Miracle has signed a letter of intent with FF AI-Robotics to support the “Robotics Partnership Program” in North America. The partners plan to build a network of showrooms, operations and service centers; Nature’s Miracle will handle marketing, customer operations and infrastructure development, while FF will provide product training and operational support. Nature’s Miracle has already received deliveries of FF robots, and program participants are expected to be able to earn revenue over the robots’ lifecycle. The company is expanding its focus to robotics and AI infrastructure but faces significant financial problems, including low market capitalization, high debt and a sharply fallen share price. » Más en de.investing.com
Nature’s Miracle Holding: Q3‑2025 financial report no longer reliable due to omission of short‑term loans
Nature’s Miracle Holding said the previously issued unaudited consolidated financial statements and disclosures for the quarter ended September 30, 2025 are no longer reliable due to an omission related to short‑term loans. Management announced it will file an amended Form 10‑Q/A to properly account for the loan and has discussed the matter with its auditors and the audit committee. » Más en de.investing.com
Nature’s Miracle settles USD 6.9m debt by issuing shares to Megaphoton
Nature’s Miracle settles trade payables of USD 6.9 million to Megaphoton by issuing 15 million common shares at USD 0.46 per share (about 13% of share capital) and also reimburses USD 300,000 in legal costs. The transaction ends the lawsuit ongoing since 2022, results in a one‑time gain of USD 6.9 million and increases equity in Q1 2026. Despite the relief, the financial position remains strained: the stock trades around USD 0.05 and the liquidity ratio is only 0.12. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | mar 2026 | |
|---|---|---|
| Ingresos | 35,94k | 96,49% |
| Beneficio bruto | −144,53k | 189,19% |
| Beneficio neto | 2,46M | 231,64% |
| EBITDA | −792,76k | 11,31% |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 17,57k€ |
Número de acciones | 20,48M |
Máximo/mínimo de 52 semanas | 0,39€ - 0,000515€ |
| Dividendos | No |
Beta | 0,69 |
Ratio P/E | 0,00 |
Ratio PEG | 0,00 |
Ratio P/B | −0,02 |
Ratio P/S | 0,03 |
Perfil de la empresa
| Nombre | Nature's Miracle Aktie |
| CEO | Tie Li |
| Empleados | 11 |
Descubrir activos
Los accionistas de Nature's Miracle Aktie también invierten en los siguientes activos





